Seer (SEER) Interest & Investment Income (2020 - 2026)
Seer (SEER) recorded quarterly Interest & Investment Income of $2.2 million in Q1 2026, down 12.68% quarter-over-quarter from $2.5 million in Q4 2025, and down 30.84% on a YoY basis from $3.2 million in Q1 2025.
Seer (SEER) Interest & Investment Income (2020 - 2026) Analysis & Trends
Seer's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 30.84% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $10.5 million (down 31.16% YoY), while the FY2025 annual figure was $11.5 million, down 30.87% from the prior year.
- Interest & Investment Income was $2.2 million for Q1 2026 at Seer, down from $2.5 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.8 million in Q3 2023 to a low of $144000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $3.1 million across 5 years, with a median of $3.2 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 2693.48% in 2022, then plunged 32.51% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $2.5 million in 2022, then surged by 89.03% to $4.7 million in 2023, then fell by 24.47% to $3.6 million in 2024, then decreased by 28.53% to $2.5 million in 2025, then dropped by 12.68% to $2.2 million in 2026.
- The last three Interest & Investment Income figures came in at $2.2 million (Q1 2026), $2.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Seer | 96.59 Mn | 96.59 Mn | 982,000.00 | 2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 4.77 Mn |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 676,000.00 |
| Mar 31, 2022 | 144,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 55,000.00 |